Your browser doesn't support javascript.
loading
The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib.
Di Vito, Aldo; Ravegnini, Gloria; Gorini, Francesca; Aasen, Trond; Serrano, César; Benuzzi, Eva; Coschina, Emma; Monesmith, Sarah; Morroni, Fabiana; Angelini, Sabrina; Hrelia, Patrizia.
Afiliación
  • Di Vito A; Department of Pharmacy and Biotechnology, University of Bologna, Italy.
  • Ravegnini G; Department of Pharmacy and Biotechnology, University of Bologna, Italy.
  • Gorini F; Department of Pharmacy and Biotechnology, University of Bologna, Italy.
  • Aasen T; Patologia Molecular Translacional, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
  • Serrano C; Sarcoma Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Benuzzi E; Department of Pharmacy and Biotechnology, University of Bologna, Italy.
  • Coschina E; Department of Pharmacy and Biotechnology, University of Bologna, Italy.
  • Monesmith S; Department of Pharmacy and Biotechnology, University of Bologna, Italy.
  • Morroni F; Department of Pharmacy and Biotechnology, University of Bologna, Italy.
  • Angelini S; Department of Pharmacy and Biotechnology, University of Bologna, Italy; Inter-Departmental Center for Health Sciences & Technologies, CIRI-SDV, University of Bologna, Bologna, Italy. Electronic address: s.angelini@unibo.it.
  • Hrelia P; Department of Pharmacy and Biotechnology, University of Bologna, Italy.
Pharmacol Ther ; 248: 108475, 2023 08.
Article en En | MEDLINE | ID: mdl-37302758

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tumores del Estroma Gastrointestinal / Neoplasias Gastrointestinales / Antineoplásicos Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tumores del Estroma Gastrointestinal / Neoplasias Gastrointestinales / Antineoplásicos Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Italia